Focality of upper and lower motor neuron degeneration at the clinical onset of ALS
Abstract
Objective: To localize and analyze the anatomic distribution of upper motor neuron (UMN) and lower motor neuron (LMN) loss in patients with ALS early in their disease when motor manifestations were still relatively focal using clinical examination signs.
Methods: We reviewed records of 100 patients with ALS who were evaluated when the diagnosis was first established or suspected. From the patient history, we ascertained the body region of first symptoms and the time course. From the physical examination, we separately graded severity of UMN and LMN signs in each body region, indexed these to the body region of first symptoms, and sorted and analyzed the data.
Results: Motor manifestations began in one body region in 98% of patients. UMN and LMN signs were both maximal in these same body regions, but they were independent of each other in severity and their outward distribution, which conformed to neuronal anatomy. The outward distribution of both UMN and LMN signs seemed more directed to caudal body regions than to rostral ones.
Conclusions: Motor neuron degeneration in ALS is a focal process at both upper and lower motor neuron levels of the motor system. At each level, it begins corresponding to the same peripheral body region and then advances contiguously and separately to summate over time.
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
REFERENCES
1.
Gowers WR. Manual of diseases of the nervous system. London: Churchill, 1886–1888 (reprinted special edition, Birmingham, AL: Classics of Medicine Library, 1981).
2.
Jokelainen M. Amyotrophic lateral sclerosis in Finland II: clinical characteristics. Acta Neurol Scandinav 1977;56:194–204.
3.
Mulder DW. Clinical limits of amyotrophic lateral sclerosis. In: Rowland LP, ed. Human motor diseases. New York: Raven Press, 1982, pp 15–22.
4.
Gubbay SS, Kahana E, Zilber N, et al. Amyotrophic lateral sclerosis: a study of its presentation and prognosis. J Neurol 1985;232:295–300.
5.
Caroscio JT, Mulvihill MN, Sterling R, et al. Amyotrophic lateral sclerosis: its natural history. Neurol Clin 1987;5:1–8.
6.
Brooks BR. The role of axonal transport in neurodegenerative disease spread: a meta-analysis of experimental and clinical poliomyelitis compares with amyotrophic lateral sclerosis. Can J Neurol Sci 1991;18:435–438.
7.
DeJong RN. The neurologic examination. incorporating the fundamentals of neuroanatomy and neurophysiology. 4th ed. Hagerstown: Harper & Row, 1979.
8.
Cwik VA. ALS clinical motor signs and symptoms, Chapter 5. In: Mitsumoto H, Przedborski S, Gordon PH, eds. Amyotrophic lateral sclerosis. New York: Taylor & Francis, 2006:99–115.
9.
Tourtellotte WW, Syndulko K. Quantifying the neurologic examination: principles, constraints, and opportunities, Chapter 2. In: Munsat TL, ed. Quantification of neurologic deficit. Boston: Butterworths, 1989:7–16.
10.
Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293–299.
11.
DeJong RN. The stretch reflexes, Chapter 33. In: The neurologic examination: Incorporating the fundamentals of neuroanatomy and neurophysiology. 4th ed. Hagerstown: Harper & Row, 1979:431–445.
12.
LaRocca NG. Statistical and methodologic considerations in scale construction, Chapter 5. In: Munsat TL, ed. Quantification of neurologic deficit. Boston: Butterworths, 1989:49–68.
13.
The ALS CNTF Treatment Study (ACTS) Phase I-II Study Group: The Amyotrophic Lateral Sclerosis Functional Rating Scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 1996;53:141–147.
14.
Brooks BR, DePaul R, Tan YD, et al. Motor neuron disease, Chapter 18. In: Schoenberg BS, Porter R, eds. Controlled clinical trials in neurology. Norwood: Marcel Dekker, 1990:249–281.
15.
Ono M, Kubik S, Abernathey C. Atlas of the cerebral sulci. Stuttgart: Verlag, 1990:151–161.
16.
Ravits J, Fan Y, Laurie P, Cheteni F. Personal observations.
17.
Swash M. Vulnerability of lower brachial myotomes in motor neurone disease: a clinical and single fibre EMG study. J Neurol Sci 1980;47:59–68.
18.
Swash M, Leader M, Brown A, Swettenham KW. Focal loss of anterior horn cells in the cervical cord in motor neuron disease. Brain 1986;109 (pt 5):939–952.
19.
Charcot J-M. Des amyotrophies chroniques—atrophie musculaire progressive spinale prototypique. In: Oeuvres Complètes. Vol 2. Paris: Bureaux du Progrès Mèdical, 1874:221–233. (In English: Chronic spinal amyotrophies: protopathic spinal progressive muscular atrophy. In: Sigerson G, translator. Lectures on diseases of the nervous system. London: New Sydenham Society, 1881:233–248.)
20.
Charcot J-M. Sclérose latérale amyotrophique. In: Oeuvres Complètes. Vol 2. Paris: Bureaux du Progrès Mèdical, 1897:249–266. (In English: Amyotrophic lateral sclerosis: symptomatology. In: Sigerson G, translator. Lectures on diseases of the nervous system. London: New Sydenham Society, 1881:192–204.)
21.
Kiernan JA, Hudson AJ. Changes in sizes of cortical and lower motor neurons in amyotrophic lateral sclerosis. Brain 1991;114:843–853.
22.
Nihei K, McKee AC, Kowall NW. Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis. Acta Neuropathol 1993;86:55–64.
23.
Pamphlett R, Kril J, Hng TM. Motor neuron disease: a primary disorder of corticomotor neurons? Muscle Nerve 1995;18:314–318.
24.
Mochizuki Y, Mizutani T, Takasu T. Amyotrophic lateral sclerosis with marked neurological asymmetry: clinicopathological study. Acta Neuropathol 1995;90:44–50.
25.
Sharrard WJW. The distribution of permanent paralysis in the lower limbs in poliomyelitis. J Bone Joint Surg 1955;37B:540–558.
26.
Wohlfart G. Collateral regeneration in partially denervated muscles. Neurol 1958;8:175–180.
27.
Hansen S, Ballantyne JP. A quantitative electrophysiological study of motor neurone disease. J Neurol Neurosurg Psychiatry 1978;41:773–783.
28.
Swash M, Ingram D. Preclinical and subclinical events in motor neuron disease. J Neurol Neurosurg Psychiatry 1988;51:165–168.
29.
de Carvalho M, Swash M. The onset of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2006;77:388–389.
30.
Porter R, Lemon R. Corticospinal function and voluntary movement. Oxford, UK: Clarendon Press, 1993:421.
31.
Abmayr S, Weydt P. Skeletal muscle in amyotrophic lateral sclerosis: emerging concepts and therapeutic implications. Phys Med Rehabil Clin N Am 2005;16:1091–1097.
32.
Eisen A, Kim S, Pant B. Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotorneuron? Muscle Nerve 1992;15:219–228.
33.
Eisen A, Weber M. The motor cortex and amyotrophic lateral sclerosis. Muscle Nerve 2001;24:564–573.
34.
Chou SM, Norris FH. Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons. Muscle Nerve 1993;9:864–869.
Information & Authors
Information
Published In
Copyright
© 2007.
Publication History
Published online: May 7, 2007
Published in print: May 8, 2007
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Daily Assistance for Amyotrophic Lateral Sclerosis Patients Based on a Wearable Multimodal Brain-Computer Interface Mouse, IEEE Transactions on Neural Systems and Rehabilitation Engineering, 33, (150-161), (2025).https://doi.org/10.1109/TNSRE.2024.3520984
- The burden of upper motor neuron involvement is correlated with the bilateral limb involvement interval in patients with amyotrophic lateral sclerosis: a retrospective observational study, Neural Regeneration Research, 20, 5, (1505-1512), (2024).https://doi.org/10.4103/NRR.NRR-D-23-01359
- Physiological Biomarkers of Upper Motor Neuron Dysfunction in ALS, Brain Sciences, 14, 8, (760), (2024).https://doi.org/10.3390/brainsci14080760
- Automatic detection of ALS from single-trial MEG signals during speech tasks: a pilot study, Frontiers in Psychology, 15, (2024).https://doi.org/10.3389/fpsyg.2024.1114811
- Potential contribution of spinal interneurons to the etiopathogenesis of amyotrophic lateral sclerosis, Frontiers in Neuroscience, 18, (2024).https://doi.org/10.3389/fnins.2024.1434404
- Association Between Hypothalamic Volume and Metabolism, Cognition, and Behavior in Patients With Amyotrophic Lateral Sclerosis, Neurology, 103, 2, (2024)./doi/10.1212/WNL.0000000000209603
- The Lateral Corticospinal Tract Sign: An MRI Marker for Amyotrophic Lateral Sclerosis, Radiology, 312, 3, (2024).https://doi.org/10.1148/radiol.231630
- Spinal inhibitory neurons degenerate before motor neurons and excitatory neurons in a mouse model of ALS, Science Advances, 10, 22, (2024).https://doi.org/10.1126/sciadv.adk3229
- Possible changes in motor neuron discharge characteristics in presymptomatic amyotrophic lateral sclerosis, The Journal of Physiology, 602, 24, (6631-6635), (2024).https://doi.org/10.1113/JP287788
- Theme 2 Genetics and Genomics, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25, sup1, (105-121), (2024).https://doi.org/10.1080/21678421.2024.2403299
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.